Log in to save to my catalogue

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3c042d9b98fa4ee286377da04fba1f4e

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes

About this item

Full title

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes

Publisher

New York: Springer US

Journal title

Nanoscale research letters, 2017-11, Vol.12 (1), p.585-10, Article 585

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Bufalin was reported to show strong pharmacological effects including cardiotonic, antiviral, immune-regulation, and especially antitumor effects. The objective of this study was to determine the characterization, antitumor efficacy, and pharmacokinetics of bufalin-loaded PEGylated liposomes compared with bufalin entity, which were prepared by FDA-...

Alternative Titles

Full title

Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_3c042d9b98fa4ee286377da04fba1f4e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3c042d9b98fa4ee286377da04fba1f4e

Other Identifiers

ISSN

1931-7573

E-ISSN

1556-276X

DOI

10.1186/s11671-017-2346-8

How to access this item